Study of 750,000 pregnancies reveals a surprising twist about Ozempic and Wegovy

Friday, November 13, 2026

Want headlines delivered to your inbox?
Subscribe to our free daily newsletter.

Search Headlines:

Match Type:BroadStrict



A study of more than 750,000 pregnancies found that early exposure to Ozempic, Wegovy, and similar drugs was not linked to increased pregnancy complications when used for weight loss, but was associated with a higher risk of premature birth when prescribed for diabetes. The surprising difference suggests that diabetes itself may be driving the risk, although researchers caution that the drugs' safety during pregnancy remains uncertain. (via Science Daily)

Read the Full Story
This article will expire in 29 days.

In the News...

View All Recent News

Note: News headlines appearing on this site do not reflect the opinion of RxChat.com or its staff.